ON
BeOne Medicines AG
ONC · NASDAQ
$350.84 -0.37% (-$1.29)
1M -5.68%
Market Cap $37.5B
P/E Ratio 57.18x
Div. Yield -
ROE 14.24%
Bulios Fair Price
$356.47
1.6% upside
Current Price
$350.84
Undervalued Fair Value Overvalued
According to Bulios Fair Price, ONC is currently trading close to its fair value. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Moderate
6/9Valuation
16 /100
Expensive EV/EBITDA 28.93x
P/S 6.12x
P/B 7.25x
Growth
83 /100
Growing Book val. growth 0.17%
Rev. growth 55.69%
FCF growth N/A
Profitability
83 /100
Strong Net margin 10.70%
Op. margin 15.06%
FCF margin 20.28%
Quality
60 /100
Average ROE 14.24%
ROA 7.15%
Asset turnover 0.67x
Debt
100 /100
Low Current ratio 3.40x
Int. coverage 13.83x
Net debt/EBITDA -3.41x
Stability
43 /100
Moderate Rev. volatility 16.75%
EPS volatility 336.73%
Profitable years 1
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about ONC
Online
Sector
Healthcare
Industry
Biotechnology
CEO
John V. Oyler
Employees
12,000
Headquarters
Basel
Upcoming events
05 NOV
Earnings
Upcoming earnings report